Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration entities : Amgen inc. save search
Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and Collaboration
Published: 2023-09-04 (Crawled : 16:00) - prnewswire.com
MREO | $2.64 -0.38% -0.38% 910K
|
Health Technology
| Email alert
Add to watchlist
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
| Email alert
Add to watchlist
KIDS | $30.35 3.02% 2.93% 140K
|
Health Technology
| Email alert
Add to watchlist
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
RARE F | $42.37 -2.33% -2.38% 680K
|
Health Technology
| Email alert
Add to watchlist
treatment research global collaboration growth
Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease
Published: 2023-05-09 (Crawled : 13:00) - globenewswire.com
TCRX 1 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: 27.58%
H: 110.1%
C: 18.47%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -3.11%
H: 0.6%
C: -0.14%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.01%
H: 0.34%
C: -0.09%
disease collaboration therapeutics
Global Peptide Therapeutics Market to Grow by USD 23.36 Bn, Collaboration for research and development to be the Key Trend - Technavio
Published: 2022-11-02 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.27%
H: 2.19%
C: -3.32%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.21%
H: 0.0%
C: -0.14%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.8%
H: 1.45%
C: 0.81%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.63%
H: 0.61%
C: -1.2%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: -2.87%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.75%
H: 1.66%
C: -1.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.15%
H: 1.19%
C: -0.97%
research global collaboration therapeutics market
IDEAYA Announces Clinical Trial Collaboration with Amgen to Evaluate MAT2A-PRMT5 Synthetic Lethality Combination in MTAP Deleted Tumors
Published: 2022-07-27 (Crawled : 11:00) - biospace.com/
IDYA | $37.1 -1.38% -1.4% 730K
|
Health Technology
|
| O: 1.12%
H: 2.86%
C: 1.89%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.79%
H: 1.44%
C: 1.03%
collaboration trial
AMGEN AND PLEXIUM ANNOUNCE MULTI-YEAR, DRUG DISCOVERY COLLABORATION TO IDENTIFY NOVEL TARGETED PROTEIN DEGRADATION THERAPIES
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -5.61%
H: 0.0%
C: -7.64%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.12%
H: 0.15%
C: -2.02%
drug multi-year collaboration drug discovery therapy
BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with LUMAKRAS® (sotorasib) in Advanced Solid Tumors with the KRAS G12C Mutation
Published: 2022-01-13 (Crawled : 12:30) - globenewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -5.11%
H: 1.25%
C: -4.2%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
bbp-398 lumakras solid tumors potential collaboration
AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA DEGRADER SMALL MOLECULE THERAPEUTICS
Published: 2022-01-11 (Crawled : 15:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
therapeutics collaboration
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.77%
H: 4.53%
C: 4.35%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.69%
H: 1.88%
C: 0.28%
disease collaboration therapy train
Asieris and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of APL-1202 and Tislelizumab
Published: 2021-05-06 (Crawled : 14:15) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 0.14%
H: 3.67%
C: 2.67%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.03%
H: 0.88%
C: 0.81%
collaboration
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease
Published: 2021-01-11 (Crawled : 17:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.46%
H: 2.91%
C: 2.48%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.55%
H: 1.0%
C: -0.04%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.63%
H: 0.15%
C: -1.01%
collaboration disease cancer announces collaboration
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.